Buyouts
Western sellers could do more to understand Chinese buyers - China M&A Forum
Western sellers should do more to understand Chinese buyers rather than backing away from potentially superior bids due to concerns about regulatory approvals, industry participants told the China M&A Forum.
INCJ, Konica Minolta acquire Ambry Genetics for $1b
Innovation Network Corporation of Japan (INCJ) and imaging giant Konica Minolta have completed a $1 billion joint acquisition of US-based Ambry Genetics, with a view to growing the company in Japan.
3Q analysis: More about Japan
Toshiba sends Japan into top spot for investment amid corporate carve-out excitement; fundraising plummets in the absence of Chinese state-backed vehicles; the IPO window opens as public markets boom
IMM to buy Korean fashion e-commerce business
IMM Private Equity has agreed to buy a majority stake in W Concept Korea, an own-brand online clothing retailer owned by ISE Commerce, a multi-strategy Korean e-commerce business.
Portfolio: J-Star and Japan Hospice Holdings
In 2014 J-Star bet on a pair of pioneering companies in Japan’s hospice care market. Now the resulting platform is set to dominate the still-nascent industry with high standards for care and patient dignity
Affinity to buy Burger King Japan
Affinity Equity Partners, which already owns Burger King in South Korea, has assumed control of the fast food chain’s master franchise for Japan.
ADK management offers support to Bain buyout bid
Japan-based advertising agency Asatsu-DK (ADK) has expressed its support for Bain Capital Private Equity’s proposed JPY151 billion ($1.3 billion) buyout, against opposition from its largest shareholder, WPP Group.
PE must 'play to win' in Japan carve-outs - Bain & Co
Japan private equity investment is on course for a record year on the back of increased divestment activity, but GPs must fine-tune their strategies to prevail in a highly competitive auction processes, according to Bain & Company.
Blue Ocean Capital exits China Cord Blood
China-focused PE firm Blue Ocean Capital has exited US-listed China Cord Blood Corporation (CCBC), by selling its beneficial interest in the blood bank operator to a fund sponsored by Chinese conglomerate Sanpower Group.
China-Australia: Communication breakdown
A couple of high-profile rejections of Chinese deals overshadow the fact that most foreign investments in the country receive approval. Prospective buyers are advised to engage with interested parties from the outset
Tech M&A: Tactical forays
A new generation of Chinese technology companies – conscious of the need to stay competitive – are becoming more active M&A players as they choose to buy rather than build their way into multiple verticals
KKR sweetens tender offer for Japan's Hitachi Kokusai
KKR has improved its tender offer for Japanese high-tech manufacturer Hitachi Kokusai Electric after the process, which was announced in April, stalled due to share price volatility.
China M&A: Exit options
The growth in outbound M&A among Chinese investors has created significant exit opportunities for PE investors
Regulation: Dialogue in the dark
The Committee on Foreign Investment in the US has a huge a backlog of applications to process and a staffing shortage. Potential buyers have little choice but to be patient
Q&A: Zhong Lun's Yun Zhou
Yun Zhou, a partner with Chinese law firm Zhong Lun, discusses the effects of Chinese government guidelines on outbound investment in terms of who will be doing these deals, and how
One Belt One Road: Probationary bonanza
China’s One Belt One Road agenda is set to be a driving force in M&A activity that reshapes economies across Eurasia for decades to come. Early movers are consequently negotiating a new world of variables
China M&A: Outbound 2.0
Following the issuance of regulatory guidance, the aggression and opportunism that once characterized corporate China’s approach to overseas M&A will be replaced by moderation and consideration
India's Samara acquires drug portfolio from Novartis
Samara Capital Partners has acquired the Indian rights to a portfolio of drug brands from Swiss pharmaceutical company Novartis.
Provident joins $138m bid for Indonesian mining project
Provident Capital has joined a consortium of investors in a bid to acquire Finders Resources that values the Indonesian mining project developer at about A$177.7 million ($138 million).
Bain launches $1.3b tender offer for Japanese ad agency
Bain Capital Private Equity has launched a tender offer for Japan-based advertising agency Asatsu-DK (ADK) that values the company at JPY151 billion ($1.3 billion).
Japan carve-outs: Slow burn story
Toshiba Memory Corporation is set to become Asia'a largest-ever PE buyout, if the deal goes through in its current form. But this doesn't necessarily mean the path to corporate divestments in Japan will become smoother
MBK to buy stake in Korean golf course business
MBK Partners, which completed its acquisition of Japanese golf course operator Accordia Golf earlier this year, has agreed to take a stake in the golf course management business of Korea-listed Golfzon.
PE investors abandon Australia childcare merger
Outside school care providers Camp Australia and Junior Adventures Group (JAG), which are owned by Bain Capital Private Equity and Advent Partners, respectively, have abandoned plans to merge.
China's 51Job acquires majority stake in VC-backed Lagou
US-listed Chinese recruitment site 51Job has agreed to acquire a 60% stake in industry peer Beijing Lagou Network Technology, which is backed by Qiming Venture Partners and other VC investors, for $119 million.